Evoke Wealth’s HUMANIGEN, INC. HGEN Stock Holding History

Evoke Wealth’s Portfolio HGEN Stock Details HGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-1,255	Closed	-$4K	–	1271
2022 Q1	$4K	Buy	+1,255	New	+$3.36K	﹤0.01%	975

Other funds holding HGEN

VCM

Valiant Capital Management San Francisco, California $1.74B AUM 64.05% 1-Year Est. Return

Murchinson Toronto, Ontario, Canada $791M AUM 68.08% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CAC

Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Evoke Wealth's HGEN Position: Q2 2022 in Review

Evoke Wealth sold out of HUMANIGEN, INC. (HGEN) in Q2 2022, closing a stake of 1,255 shares — an estimated $4K sold.

Evoke Wealth first reported a position in HGEN in Q1 2022 and held it in 1 quarter. The position peaked at $4K in Q1 2022. 65 funds tracked by Wall St. Rank hold HGEN as of Q2 2022.

Evoke Wealth reported no remaining HUMANIGEN, INC. position as of Q2 2022 after selling out during the quarter.
Evoke Wealth sold 1,255 HUMANIGEN, INC. shares in Q2 2022, an estimated $4K.
Evoke Wealth first reported a position in HUMANIGEN, INC. in Q1 2022 and held it in 1 quarter.
Evoke Wealth's HUMANIGEN, INC. position peaked at $4K in Q1 2022.
65 funds tracked by Wall St. Rank held HUMANIGEN, INC. as of Q2 2022.

Based on Evoke Wealth's 13F filing for Q2 2022, filed 4 Aug 2022.